Ligand Pharmaceuticals (LGND) News Today $132.72 +1.14 (+0.87%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$132.72 0.00 (0.00%) As of 08/1/2025 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LGND Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period 2,519 Shares in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Bought by Pacer Advisors Inc.August 2 at 3:18 AM | marketbeat.comOppenheimer Forecasts Strong Price Appreciation for Ligand Pharmaceuticals (NASDAQ:LGND) StockJuly 31, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $2.22 Million in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 31, 2025 | marketbeat.comLigand Pharmaceuticals (LGND) Expected to Announce Quarterly Earnings on ThursdayJuly 31, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Average Recommendation of "Buy" by AnalystsJuly 30, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Holdings Decreased by Essex Investment Management Co. LLCJuly 29, 2025 | marketbeat.comVictory Capital Management Inc. Has $2.91 Million Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 29, 2025 | marketbeat.comEnvestnet Asset Management Inc. Sells 60,587 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 28, 2025 | marketbeat.comLigand Pharmaceuticals Inc (LGND) Announces Upcoming Q2 2025 Financial Results Release | LGND ...July 24, 2025 | gurufocus.comLigand to Report Second Quarter 2025 Financial Results on August 7, 2025July 24, 2025 | globenewswire.comLigand Pharmaceuticals (NASDAQ:LGND) Sets New 52-Week High - Time to Buy?July 22, 2025 | marketbeat.comBank of New York Mellon Corp Sells 3,421 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 21, 2025 | marketbeat.comNew York State Common Retirement Fund Increases Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 19, 2025 | marketbeat.comJackson Creek Investment Advisors LLC Trims Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 18, 2025 | marketbeat.comStocks Showing Rising Market Leadership: Ligand Pharmaceuticals Earns 84 RS RatingJuly 18, 2025 | msn.comLigand Pharmaceuticals Stock Earns 84 RS RatingJuly 17, 2025 | msn.comJ&J boosts full-year outlook on forex tailwinds and operational performanceJuly 16, 2025 | msn.comLigand Pharmaceuticals (NASDAQ:LGND) Reaches New 52-Week High - Still a Buy?July 16, 2025 | marketbeat.comLigand Pharmaceuticals Shows Rising Price Performance With Jump To 82 RS RatingJuly 15, 2025 | msn.comCenterBook Partners LP Purchases 44,760 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 15, 2025 | marketbeat.comRice Hall James & Associates LLC Sells 7,704 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 14, 2025 | marketbeat.comPrincipal Financial Group Inc. Acquires 3,284 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 14, 2025 | marketbeat.comStephens Investment Management Group LLC Reduces Stock Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 13, 2025 | marketbeat.comLigand Pharmaceuticals Partner Pelthos Therapeutics Launches ... - NasdaqJuly 12, 2025 | nasdaq.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Director John W. Kozarich Sells 934 SharesJuly 12, 2025 | insidertrades.comInsider Sell Alert: John Kozarich Sells Shares of Ligand Pharmaceuticals Inc (LGND)July 11, 2025 | gurufocus.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Director Sells $116,750.00 in StockJuly 11, 2025 | marketbeat.comLigand Pharmaceuticals Insider Trading Activity | NASDAQ:LGND | BenzingaJuly 11, 2025 | benzinga.comLigand Pharmaceuticals: Ligand Partner Pelthos Therapeutics Launches ZELSUVMIJuly 10, 2025 | finanznachrichten.deLigand Partner Pelthos Therapeutics Launches ZELSUVMI™July 10, 2025 | globenewswire.comLigand Pharmaceuticals (NASDAQ:LGND) Shares Up 5% - Here's What HappenedJuly 9, 2025 | marketbeat.comCalamos Advisors LLC Has $2.10 Million Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 6, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (LGND) - Yahoo FinanceJuly 5, 2025 | finance.yahoo.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives Average Recommendation of "Buy" from AnalystsJuly 5, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Has $10.14 Million Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 4, 2025 | marketbeat.comLigand, Pelthos Close Merger Deal With Channel's CHRO; To Launch ZELSUVMI In JulyJuly 2, 2025 | finanznachrichten.deLigand Announces Completion of Pelthos Therapeutics Merger with Channel TherapeuticsJuly 2, 2025 | globenewswire.comPelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private PlacementJuly 2, 2025 | globenewswire.comLisanti Capital Growth LLC Acquires 13,565 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)June 29, 2025 | marketbeat.comLGND Ligand Pharmaceuticals Incorporated - Seeking AlphaJune 26, 2025 | seekingalpha.comAndrew Reardon Sells 500 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) StockJune 26, 2025 | insidertrades.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Insider Sells $57,040.00 in StockJune 25, 2025 | marketbeat.comLigand Pharmaceuticals: Attractive Royalty Model Powers ForwardJune 24, 2025 | seekingalpha.comAdvisor Resource Council Makes New $2.24 Million Investment in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)June 21, 2025 | marketbeat.comSG Americas Securities LLC Acquires 5,201 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)June 21, 2025 | marketbeat.comChicago Capital LLC Has $58.30 Million Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)June 17, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Takes $286,000 Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)June 16, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Insider Sells $57,270.00 in StockJune 13, 2025 | insidertrades.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Insider Andrew Reardon Sells 500 SharesJune 12, 2025 | marketbeat.comLGND Makes Bullish Cross Above Critical Moving AverageJune 11, 2025 | nasdaq.com Get Ligand Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LGND and its competitors with MarketBeat's FREE daily newsletter. Email Address LGND Media Mentions By Week LGND Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LGND News Sentiment▼1.320.46▲Average Medical News Sentiment LGND News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LGND Articles This Week▼96▲LGND Articles Average Week Get Ligand Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LGND and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ADMA News Today ANIP News Today EXAS News Today HALO News Today RGEN News Today MDGL News Today IONS News Today ALKS News Today FOLD News Today BCRX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LGND) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | SponsoredWhat does Wall Street do all day?One major gold miner I’ve been pounding the table on for months just reported blowout earnings—driven by recor...Golden Portfolio | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ligand Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Ligand Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LGND Stock Alerts